10% CAGR Embolic Protection Devices Market pour to hit USD 1.8 Bn By 2024

Selbyville, DE -- (SBWire) -- 11/06/2018 --The Embolic Protection Devices Market to exceed USD 1.8 billion by 2024; according to a new research study published by Global Market Insights, Inc.

The demand for embolic protection devices is predominantly driven by the increasing adoption of minimally invasive heart procedures such as carotid artery stenting and transcatheter aortic valve replacement (TAVR). Moreover, growing awareness among physicians regarding risks of brain injuries during cardiovascular interventions should drive the market penetration of embolic protection devices.
Increasing aging population has further contributed to rise in number of cardiovascular disease deaths globally. According to estimates, the percentage of population aged 60 and above is likely to reach to 1.6 billion by 2050. Since, aging is one of the significant factors responsible for cardiovascular diseases, the potential patient pool serves as a huge market opportunity for embolic protection devices in the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2417

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Medtronic
- Kalila Medical (Abbott Laboratories)
- Allium Medical
- Keystone Heart Ltd.
- Boston Scientific
- Cardinal Health
- Metactive Medical, Inc.
- Contego Medical, LLC
- Edward Lifescience
- Transverse Medical Inc

Carotid artery diseases segment contributed largest share to the overall embolic protection devices market, mainly due to increase in the number of carotid artery stenting procedures. The adoption of minimally invasive procedures has led to popularity of carotid artery stenting over carotid endarterectomy. Further, increasing prevalence of carotid artery diseases should drive the segment growth during forecast period.
Peripheral artery diseases segment represents a significant market opportunity, since this segment is less penetrated. Embolic protection is required to prevent blood clots travelling into blood stream during peripheral artery interventions.

Distal filters are the largest revenue generators in embolic protection devices market owing to the advantages offered such as easy deployment, maintenance of antegrade blood flow, and non-interference with lesion visualization. Most of the manufacturers operating in this industry provide distal filter embolic protection devices.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2417

U.S. dominated the embolic protection devices market in 2016. The largest share of the region should be attributed to increasing aging population. People aged 65 and above are set to increase to 20% of U.S. population in 2030 from 13% in 2000. In addition, increased adoption of new technologies to reap immediate benefits and favorable reimbursement scenario should further propel embolic protection devices market.

Embolic Protection Devices Market by Product
- Distal Occlusion Systems
- Proximal Occlusion Systems
- Distal Filters
Embolic Protection Devices Market by Application
- Carotid Artery Diseases
- Coronary Artery Diseases
- Peripheral Vascular Diseases